Diffuse Hemispheric Glioma, H3 G34-Mutant

Diffuse Hemispheric Glioma, H3 G34-Mutant — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Institute of Cancer Research, United Kingdom
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05843253	Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant	recruiting	Phase 2	120	Nationwide Children's HospitalOTHER	6	May 29, 2026	clinicaltrials
NCT06630260	5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours(5G-RUBY)	recruiting	Phase 1 / Phase 2	182	Institute of Cancer Research, United KingdomOTHER	1	Jan 21, 2026